[What type of evidence is currently being considered in the development of clinical practice guidelines for rare diseases? - rapid report]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018002859
German
Original Title:
Welche Evidenz wird fuer die Erstellung von Leitlinien fuer seltene Erkrankungen derzeit herangezogen?
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/v10-01.html
Year Published:
2011
URL for published report:
https://www.iqwig.de/download/V10-01_Rapid-Report_Evidenz_fuer_Leitlinien_zu_seltenen_Erkrankungen.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Practice Guidelines as Topic
- Rare Diseases
- Outcome Assessment, Health Care
- Systematic Reviews as Topic
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.